Acxiom® Corporation (Nasdaq: ACXM) today announced that its Board of Directors voted on August 16 to expand its membership from nine to 10 directors and appointed Richard Fox, an acclaimed business consultant and financial expert, to the board. The company also announced that on August 16 its Audit/Finance Committee Chairman, Kevin Twomey, advised the board that he does not plan to seek re-nomination after his current term ends in August 2013.
“Kevin informed the board earlier this year that he was going through a process of considering steps to reduce his future time and travel commitments,” said Jerry Gramaglia, non-executive chairman of the Board of Directors. “We are grateful for his past service and are very pleased that he will continue actively serving on the board for the next twelve months as a member of the Compensation Committee and as chair of the Audit/Finance Committee.”
Fox was appointed to serve in the class of directors whose terms end at the 2013 annual stockholders meeting and was named a member of the board’s Compensation Committee and Audit/Finance Committee. It is anticipated that he will assume the role of Audit/Finance Committee chair when Mr. Twomey’s term ends.
“Rick brings a strong background in public company financial and accounting matters that is complemented by his work with digital marketing companies. We have added another outstanding person to our board,” said Mr. Gramaglia. “His depth and breadth of experience will be of significant benefit to help move Acxiom forward.”Fox began his career in 1969 with Ernst & Young, specializing in high tech, software and manufacturing clients. He was managing partner of the Seattle office when he left the firm in 1997, after which he served in management positions with PACCAR, Wall Data and, most recently, CyberSafe Corporation , an enterprise security software and software services business where he served as president and chief operating officer. Fox currently serves on the board of directors of Flow International, a machine tool manufacturer (Nasdaq: FLOW); Univar Inc., an international chemical distributor; and Pendrell Corporation, an intellectual property investment and advisory firm (Nasdaq: PCO). He is also a member of the board of directors of Scottsdale Healthcare and the board of visitors of Fuqua School of Business at Duke University. He was named Public Company Director of the Year by the Seattle-Northwest Chapter of the National Association of Corporate Directors in 2008.